X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Consumer with Dabur - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs DABUR - Comparison Results

GSK CONSUMER    Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DABUR 
   Change

With over 125 years of existence, Dabur India is the fourth largest FMCG company in India. The company has a distinct positioning on the traditional Ayurvedic healthcare system having presence in personal care, health care and food. Domestic consumer... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER DABUR GSK CONSUMER/
DABUR
 
P/E (TTM) x 34.6 42.8 80.8% View Chart
P/BV x 9.3 13.1 70.7% View Chart
Dividend Yield % 1.3 0.7 179.2%  

Financials

 GSK CONSUMER   DABUR
EQUITY SHARE DATA
    GSK CONSUMER
Mar-16
DABUR
Mar-16
GSK CONSUMER/
DABUR
5-Yr Chart
Click to enlarge
High Rs6,771317 2,139.2%   
Low Rs5,448231 2,355.4%   
Sales per share (Unadj.) Rs1,024.448.1 2,131.6%  
Earnings per share (Unadj.) Rs163.37.1 2,293.4%  
Cash flow per share (Unadj.) Rs177.07.9 2,245.4%  
Dividends per share (Unadj.) Rs70.002.25 3,111.1%  
Dividend yield (eoy) %1.10.8 139.5%  
Book value per share (Unadj.) Rs581.523.6 2,458.7%  
Shares outstanding (eoy) m42.061,759.10 2.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.05.7 104.6%   
Avg P/E ratio x37.438.5 97.3%  
P/CF ratio (eoy) x34.534.8 99.3%  
Price / Book Value ratio x10.511.6 90.7%  
Dividend payout %42.931.6 135.7%   
Avg Mkt Cap Rs m256,959481,817 53.3%   
No. of employees `0003.76.6 56.5%   
Total wages/salary Rs m5,0947,948 64.1%   
Avg. sales/employee Rs Th11,548.512,795.6 90.3%   
Avg. wages/employee Rs Th1,365.31,203.0 113.5%   
Avg. net profit/employee Rs Th1,841.11,896.0 97.1%   
INCOME DATA
Net Sales Rs m43,08784,540 51.0%  
Other income Rs m2,7882,192 127.1%   
Total revenues Rs m45,87586,733 52.9%   
Gross profit Rs m8,34915,198 54.9%  
Depreciation Rs m5741,338 42.9%   
Interest Rs m8480 1.6%   
Profit before tax Rs m10,55415,572 67.8%   
Minority Interest Rs m0-27 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,6853,018 122.1%   
Profit after tax Rs m6,86912,527 54.8%  
Gross profit margin %19.418.0 107.8%  
Effective tax rate %34.919.4 180.2%   
Net profit margin %15.914.8 107.6%  
BALANCE SHEET DATA
Current assets Rs m37,56032,908 114.1%   
Current liabilities Rs m18,15324,699 73.5%   
Net working cap to sales %45.09.7 463.8%  
Current ratio x2.11.3 155.3%  
Inventory Days Days3947 82.6%  
Debtors Days Days3035 85.8%  
Net fixed assets Rs m5,37419,947 26.9%   
Share capital Rs m4211,759 23.9%   
"Free" reserves Rs m24,00338,403 62.5%   
Net worth Rs m24,45641,601 58.8%   
Long term debt Rs m03,415 0.0%   
Total assets Rs m44,98871,205 63.2%  
Interest coverage x1,336.933.4 3,999.4%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.01.2 80.7%   
Return on assets %15.318.3 83.7%  
Return on equity %28.130.1 93.3%  
Return on capital %43.235.6 121.3%  
Exports to sales %5.12.2 230.5%   
Imports to sales %0.41.8 22.2%   
Exports (fob) Rs m2,2111,882 117.5%   
Imports (cif) Rs m1681,484 11.3%   
Fx inflow Rs m2,8161,882 149.6%   
Fx outflow Rs m2611,530 17.0%   
Net fx Rs m2,555352 726.2%   
CASH FLOW
From Operations Rs m5,72410,826 52.9%  
From Investments Rs m-1,569-6,183 25.4%  
From Financial Activity Rs m-2,792-3,949 70.7%  
Net Cashflow Rs m1,363694 196.5%  

Share Holding

Indian Promoters % 0.0 68.6 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 5.6 14.3%  
FIIs % 12.0 19.2 62.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 6.5 227.7%  
Shareholders   26,457 123,555 21.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   HERITAGE FOOD  UNITED BREWERIES  KRBL LIMITED  ADVANTA LTD.  TATA COFFEE  

Compare GSK CONSUMER With:   COCA COLA (US)  NESTLE (Switz.)  TIGER BRANDS (S. Africa)  AVI LTD. (S. Africa)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

GSK Consumer: On the Recovery Path (Quarterly Results Update - Detailed)

Jun 20, 2017

While GSK consumer reported muted revenue growth, volumes are seen to be recovering.

GSK Consumer: Price Hike Hurts Volumes (Quarterly Results Update - Detailed)

Nov 30, 2016

GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.

ITC: Demonetisation woes pull down business growth (Quarterly Results Update - Detailed)

Feb 8, 2017

ITC Ltd has announced third quarter results of the financial year 2016-2017 (3QFY17). The company has reported 4.7% YoY and 5.7% YoY growth in revenues and net profits respectively. Here is our analysis of the results.

ITC: A Decent Quarter Amidst Challenging Environment (Quarterly Results Update - Detailed)

Dec 7, 2016

ITC has announced second quarter results of the financial year 2016-2017 (2QFY17). The company has reported 8% YoY and 10.5% YoY growth in revenues and net profits respectively.

GSK Consumer: Slowdown in demand impacts sales (Quarterly Results Update - Detailed)

Oct 5, 2016

GSK Consumer Healthcare has announced the first quarter results of the financial year 2016-2017 (1QFY17). The company's sales declined by 1.4% YoY while net profit rose by 2.9% YoY during the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Aug 18, 2017 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER - ADVANTA LTD. COMPARISON

COMPARE GSK CONSUMER WITH

MARKET STATS